Rino Rappuoli has spent more than 40 years in the vaccines field. He was CSO at Chiron Corporation, (2003-2006), Head of vaccine R&D for Novartis (2006-2015), CSO and Global Head of R&D at GSK (2015-2022). Presently he is the scientific director of the Fondazione Biotecnopolo di Siena, the Italian Institute for Pandemic Preparedness. He is also Honorary Professor, Imperial College, London, and Senior Professor, University of Siena. He is elected member of US National Academy of Sciences (NAS), the American Institute for Medical and Biological Engineering (AIMBE) the European Molecular Biology Organization (EMBO) and President, International Union of Microbiological Societies (IUMS). He has published more than 840 works in peer-reviewed journals and introduced novel scientific concepts like genetic detoxification, cellular microbiology, reverse vaccinology, and pangenome. He has developed and licensed several vaccines pertussis, meningococcus C, seasonal and pandemic influenza, meningococcus B and Respiratory Syncytial Virus. Professor Rappuoli is among the world scientific leaders dedicated to the sustainability of global health.
Professional position
- Scientific Director, Fondazione Biotecnopolo di Siena
